Abbisko Therapeutics Co, Ltd

This study is testing a new oral drug called ABSK-011, given alongside standard immunotherapy drugs, for people with advanced liver cancer that cannot be removed by surgery. The main goals are to see if the combination is safe and if it can help shrink tumors. The study will enro…

This study is testing an oral drug called ABSK021 for adults with a rare, non-cancerous joint tumor called TGCT that cannot be fully removed by surgery. The main goal is to see if the drug shrinks tumors and improves symptoms like pain and stiffness compared to a placebo. About 9…

This is the first study in people to test a new oral drug called ABSK121-NX. The main goal is to find a safe dose and see how the body processes the drug in 169 patients with advanced solid tumors that have stopped responding to standard treatments. Researchers will also look for…